News Articles

Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.

Filters
Clear all
Showing 0 of 100
Keyword Search
Open Arrow
Article Type
Open Arrow
Company
Open Arrow
Clear all
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters
Tag
Close Icon

Numinus Mails Materials for Special Meeting of Shareholders and Announces Interim Court Order for Plan of Arrangement

News
May 10, 2022
Numinus

Wellbeing Digital Sciences Becomes a Founding Sponsor of the Women in Psychedelics Network

News
May 10, 2022
Wellbeing Digital Sciences

Daniel Carcillo | Founder and CEO, Wesana Health

Spotlight
May 10, 2022
Wesana Health

Biomind Labs to Argument Which Psychedelic Medicines Will Lead the Industry Into Its Next Phase of Evolution at The National Gallery in London

News
May 9, 2022
Biomind Labs

MAPS Completes Enrollment, as Planned, for the Confirmatory Phase 3 Trial of MDMA-Assisted Therapy for PTSD

News
May 9, 2022
MAPS

COMPASS Pathways to fund study of COMP360 psilocybin in autistic adults

News
May 9, 2022
Compass Pathways

Clearmind Strengthens its Scientific Advisory Board With Substance Abuse and Mental Health Professionals

News
May 9, 2022
Clearmind Medicine

Cybin and Kernel Announce Results from Kernel Flow® Piloting of Feasibility Study Measuring Ketamine’s Effects on the Brain

News
May 9, 2022
Cybin Inc.

Optimi Health Applauds Health Canada’s Position on Drug Quality and Goods and Manufacturing Practices (GMP) for Psilocybin

News
May 9, 2022
Optimi Health

Red Light Holland Files International Patent Application for 'Find Your Dose' Customization of Microdosing Kits Based on Biometric and Movement Data

News
May 9, 2022
Red Light Holland

Numinus to Participate in Upcoming Research & Industry Conferences

News
May 9, 2022
Numinus

MindMed to Host Earnings Call to Discuss First Quarter 2022 Financial Results and Provide Business Update

News
May 9, 2022
Mind Medicine (MindMed)

Weekly Headlines | May 6th, 2022

Headlines
May 6, 2022
Compass Pathways
Optimi Health
Pharmather
PsyBio Therapeutics
Wesana Health

PsyBio Therapeutics Initiates Blood-Brain Barrier Permeability Testing for Pipeline Compounds to Enhance Portfolio Development

News
May 6, 2022
PsyBio Therapeutics

Wesana Announces Singular Focus on Drug Development Prompting a Strategic Review of its Clinics and Other Care Delivery Assets

News
May 5, 2022
Wesana Health

Awakn Life Sciences to Participate in Upcoming May 2022 Conferences

News
May 5, 2022
Awakn Life Sciences

Small Pharma to Participate in the PSYCH Symposium: London 2022

News
May 5, 2022
Small Pharma

Psyched Wellness Announces Del Mahabadi to Join as International Marketing Manager

News
May 5, 2022
Psyched Wellness

PharmaTher Announces Grant of U.S. Patent on Formulation and Production Process of Ketamine and Ketamine Analogs

News
May 5, 2022
Pharmather

Cybin Announces CYB003 Poster to be Presented at the ‘From Research to Reality’ Global Summit on Psychedelic-Assisted Therapies and Medicine

News
May 5, 2022
Cybin Inc.
No results found.
There are no results with this criteria. Try changing your search.
HomeNewsCompaniesSpotlightsSubscribe
Instagram
Twitter
RSS Feed
Email Us
©XXXX Psychedelic Finance. All rights reserved.
Privacy Policy
Core One Labs Inc.
Creso Pharma
Cybin Inc.
Enveric Biosciences
Field Trip Health
Filament Health
Havn Life
Levitee Labs
MINDCURE
Mydecine Innovations Group
NeonMind Biosciences Inc.
Novamind Inc.
Numinus
Optimi Health
Pharmather
PsyBio Therapeutics
Psyched Wellness
Psyence Group
Pure Extracts Corp
Silo Wellness
The Good Shroom Co
Tryp Therapeutics
Wesana Health
Aja Ventures
Albert Labs
Algernon Pharmaceuticals
Apex Labs Ltd.
B.More
Beckley Foundation
BetterLife Pharma
Bexson Biomedical
Biomind Labs
Bionomics
Braxia Scientific Corp.
Bright Minds
CB Therapeutics
Ceruvia Lifesciences
Clairvoyant Therapeutics
Clearmind Medicine
Clexio Biosciences
Cognetivity Neurosciences
Cube Psytech
Delic
Delix Therapeutics
Diamond Therapeutics
Ehave
FSD Pharma
Fluence
Freedom to Operate
HMNC Brain Health
Horizons ETFs Management Inc.
Incannex Healthcare
IntelGenx
Irwin Naturals
Ixtlan Bioscience
Johns Hopkins Medicine
MYND Diagnostics
Mind Medicine (MindMed)
MindBio Therapeutics
Mindset Pharma
Mycotopia Therapies
Mycrodose Therapeutics
Neural Therapeutics
Ninnion
Nirvana Life Sciences
Nova Mentis Life Science
Origin Therapeutics
Osmind
Pasithea Therapeutics
Pharmala Biotech Holdings
Psilera
Psilotec Health Solutions
PsyRx
Psylo
Quantified Citizen
Reunion Neuroscience
Revitalist Lifestyle and Wellness
Revive Therapeutics
Seelos Therapeutics
Small Pharma
Telescope Innovations
TheraPsil
TripSitter
Universal Ibogaine
Wellbeing Digital Sciences
Woke Pharmaceuticals
Woven Science
ATAI Life Sciences
Awakn Life Sciences
Beckley Psytech
Compass Pathways
Doseology Sciences
EI.ventures
Eleusis
Entheon Biomedical
Gilgamesh Pharmaceuticals
GoodCap Wellness
Lobe Sciences
Lophora
MAPS